Advertisement

Construction of Recombinant Vaccinia Virus Expressing HCV Genes

  • Joyce A. Feller
Part of the Methods in Molecular Medicine™ book series (MIMM, volume 19)

Abstract

Hepatitis C virus (HCV) remains the leading cause of non-A, non-B hepatitis, and a major indicator for orthotopic liver transplantation. To date, finding a cure or even a commonly effective therapy for infection with HCV has proven to be an elusive goal. One major problem that has hampered attempts to develop antiviral agents is the ongoing inability to grow the virus in tissue culture. Without an efficient in vitro system for the propagation of HCV, it is difficult to generate the large amounts of viral protein needed for this sort of study; nor can the effects of known antiviral agents be assessed on the replication of HCV. Recently, some laboratories have reported preliminary evidence of HCV replication in cultured cells (1,2), but even the best of these systems does not produce significant amounts of progeny virus. Although these methods may be applicable in the future, at present they are not yet practical.

Keywords

Vaccinia Virus Thymidine Kinase Recombinant Virus Inosine Monophosphate Shuttle Plasmid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Lanford, R. E., Sureau, C, Jacob, J. R., White, R., and Fuerst, T. R. (1994) Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR. Virology 202, 606–614.PubMedCrossRefGoogle Scholar
  2. 2.
    Mizutani, T., Kato, N., Saito, S., Ikeda, M., Sugiyama, K., and Shimotohno, K. (1996) Characterization of hepatitis C virus replication in cloned cells obtained from a human T-cell leukemia virus type 1-infected cell line, MT-2. J. Virol. 70, 7219–7223.PubMedGoogle Scholar
  3. 3.
    Moss, B., Winters, E., and Cooper, J. A. (1981) Deletion of a 9000 base pair segment of the vaccinia genome that codes for nonessential polypeptides. J. Virol. 40, 387–395.PubMedGoogle Scholar
  4. 4.
    Smith, G. L. and Moss, B. (1983) Infectious poxvirus vectors have capacity for at least 25,000 base pairs of foreign DNA. Gene 25, 21–28.PubMedCrossRefGoogle Scholar
  5. 5.
    Puckett, C. and Moss, B. (1983) Selective transcription of vaccinia virus genes in template dependent soluble extracts of infected cells. Cell 35, 441–448.PubMedCrossRefGoogle Scholar
  6. 6.
    Nakano, E., Panicali, D., and Paoletti, E. (1982) Molecular genetics of vaccinia virus: demonstration of marker rescue. Proc. Natl. Acad. Sci. USA 79, 1593–1596.PubMedCrossRefGoogle Scholar
  7. 7.
    Smith, G. L. and Moss, B. (1984) Vaccinia virus expression vectors: construction, properties and applications. Biotechniques 2, 306–312.Google Scholar
  8. 8.
    Mackett, M., Smith, G. L., and Moss, B. (1985) The construction and characterization of vaccinia virus recombinants expressing foreign genes, in DNA Cloning: A Practical Approach (Glover, D. M., ed.), IRL, Oxford, UK, pp. 191–211.Google Scholar
  9. 9.
    Mackett, M., Smith, G. L., and Moss, B. (1982) Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proc. Natl. Acad. Sci. USA 79, 7415–7419.PubMedCrossRefGoogle Scholar
  10. 10.
    Panicali, D. and Paoletti, E. (1982) Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus. Proc. Natl. Acad. Sci. USA 79, 4927–4931.PubMedCrossRefGoogle Scholar
  11. 11.
    Perkus, M. E., Piccini, A., Lipinskas, B. R., and Paoletti, E. (1985) Recombinant vaccinia virus: immunization against multiple pathogens. Science 119, 981–984.CrossRefGoogle Scholar
  12. 12.
    Miller, R. L., Ramsey, G. A., Krenitsky, T. H., and Elion, G. B. (1972) Guanine phosphoribosyltransferase from Escherichia coli, specificity and properties. Biochemistry 11, 4723–4731.PubMedCrossRefGoogle Scholar
  13. 13.
    Krenitsky, T. A., Papaioannou, R., and Elion, G. B. (1969) Human hypoxanthine phosphoribosyltransferase. I. Purification, properties, and specificity. J. Biol. Chem. 244, 1263–1270.PubMedGoogle Scholar
  14. 14.
    Mulligan, R. C and Berg, P (1980) Expression of a bacterial gene in mammalian cells Science 209, 1422–1427PubMedCrossRefGoogle Scholar
  15. 15.
    Mulligan, R C and Berg, P (1981) Selection for animal cells that express the Escherichia coli gene encoding for xanthine-guanine phosphoribosyltransferase. Proc Natl Acad. Sci USA 78, 2072–2076.PubMedCrossRefGoogle Scholar
  16. 16.
    Franklin, T J and Cook, J M (1969) The inhibition of nucleic acid synthesis by mycophenolic acid Biochem. J 113, 512–524Google Scholar
  17. 17.
    Falkner, F G and Moss, B. (1988) Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors. J Virol 6, 1849–1854.Google Scholar
  18. 18.
    Boyle, D. B and Coupar, B. E H (1988) A dominant selectable marker for the construction of recombinant poxviruses. Gene 65, 123–128.PubMedCrossRefGoogle Scholar
  19. 19.
    Isaacs, S N, Kotwal, G J, and Moss, B. (1990) Reverse guanine phosphoribosyltransferase selection of recombinant vaccinia viruses Virology 178, 626–630PubMedCrossRefGoogle Scholar
  20. 20.
    Falkner, F. G and Moss, B. (1990) Transient dominant selection of recombinant vaccinia viruses. J Virol 64, 3108–3111.PubMedGoogle Scholar
  21. 21.
    Kurilla, M G (1997) Transient selection during vaccinia virus recombination with insertion vectors without selectable markers Biotechniques 22, 906–910PubMedGoogle Scholar
  22. 22.
    Moss, B, Elroy-Stein, O, Mizukami, T, Alexander, A, and Fuerst, T R (1990) Product review New mammalian expression vectors. Nature 348, 91,92.PubMedCrossRefGoogle Scholar
  23. 23.
    Yuen, L and Moss, B. (1986) Multiple 3′ ends of mRNA encoding vaccinia virus growth factor occur within a series of repeated sequences downstream of T clusters J Virol 60, 320–323PubMedGoogle Scholar
  24. 24.
    Yuen, L. and Moss, B. (1987) Oligonucleotide sequence signaling transcriptional termination of vaccinia virus early genes Proc Natl Acad Sci USA 84, 6417–6421.PubMedCrossRefGoogle Scholar
  25. 25.
    Upton, C, DeLange, A M., and McFadden, G (1987) Tumorigenic poxviruses. genomic organization and DNA sequence of the Shope fibroma virus genome Virology 187, 20–30CrossRefGoogle Scholar
  26. 26.
    Hanggi, M, Bannwarth, W., and Stunnenberg, H. G (1986) Conserved TAAAT motif in vaccinia virus late promoters, overlapping TATA box and the site of transcription initiation EMBOJ 5, 1071–1076.Google Scholar
  27. 27.
    Rosel, J. L., Earl, P. L., Weir, J P, and Moss, B (1986) Conserved TAAATG sequence at the transcriptional and translational initiation sites of vaccinia virus late genes deduced by structural and functional analysis of the HindIII H genome fragment. J Virol 60, 436–449.PubMedGoogle Scholar
  28. 28.
    Moss, B. (1990) Poxviridae and their replication, in Virology (Felds, B N., Knipe, D. M., Chanock, R. M., Hirsch, M. S., Melmck, J. L-Monath, T. P., and Roizman, B., eds), Raven, New York, pp. 2079–2111.Google Scholar
  29. 29.
    Blasco, R and Moss, B (1995) Selection of recombinant vaccinia viruses on the basis of plaque formation Gene 158, 157–162PubMedCrossRefGoogle Scholar
  30. 30.
    Pfleiderer, M, Falkner, F. G, and Dorner, F (1995) A novel vaccinia virus expression system allowing construction of recombinants without the need for selection markers, plasmids and bacterial hosts. J Gen Virol 76, 2957–2962PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 1998

Authors and Affiliations

  • Joyce A. Feller
    • 1
  1. 1.Department of Molecular Genetics and MicrobiologyUniversity of FloridaGainesville

Personalised recommendations